Form 4: Haemonetics EVP and General Counsel Michelle Basil Reports Stock Transactions
SEC Form 4
Michelle Basil, EVP and General Counsel of Haemonetics, reports the withholding of shares for tax obligations and a sale of shares under a pre-arranged 10b5-1 trading plan.
Summary
- Michelle Basil, the EVP and General Counsel of Haemonetics Corp, filed a Form 4 detailing changes in beneficial ownership.
- On May 15, 2024, 416 shares of common stock were withheld to cover tax obligations related to vesting restricted stock units at a price of $96.49.
- On May 16, 2024, an additional 446 shares were withheld for tax obligations at a price of $94.8.
- Also on May 16, 2024, 985 shares were sold at $96.14 per share under a pre-existing 10b5-1 trading plan.
- Following these transactions, Ms. Basil directly owns 30,425 shares of Haemonetics Corp common stock, including unvested RSUs.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports routine stock transactions related to tax obligations and a pre-existing trading plan.
Industry Context
Form 4 filings are a routine part of insider trading activity and are used by the SEC to ensure compliance with trading regulations. The use of a 10b5-1 trading plan indicates that the insider's sales were pre-planned and not based on inside information.
Key Dates
| Date | Description |
|---|---|
| 12/13/2023 | Date of the 10b5-1 trading plan |
| 12/14/2023 | 10b5-1 trading plan fully executed |
| 05/15/2024 | Withholding of 416 shares for tax obligations |
| 05/16/2024 | Withholding of 446 shares for tax obligations and sale of 985 shares under 10b5-1 plan |
| 05/17/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.